Renflexis 100 MG vials
Ended Awarded
- Contract number
- SPE2DB25FE1LM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,362
Award facts
- Contract value 100% obligated
- $26,361.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Renflexis 100 mg vials, a biosimilar medication used to treat inflammatory conditions. This firm fixed-price delivery order, valued at $26,361.92, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The award was made through competitive procedures with no set-aside designation, and the product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 30, 2025.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical vendor for the Defense Logistics Agency's Medical Supply Chain, distributing a comprehensive range of brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare systems worldwide. The company's SPE2DX IDC functions as a global pharmaceutical support vehicle enabling the supply of diverse therapeutic products across multiple medical domains. This delivery order for Renflexis reflects AmerisourceBergen's ongoing role in fulfilling federal medical procurement requirements through the DLA's strategic pharmaceutical sourcing initiatives.
Quick answers
Who was awarded contract SPE2DB25FE1LM?
SPE2DB25FE1LM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FE1LM worth?
The government has obligated $26,362 on SPE2DB25FE1LM.
Is contract SPE2DB25FE1LM an order under another contract?
Yes. SPE2DB25FE1LM is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE1LM competed?
The extent of competition for SPE2DB25FE1LM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award